Paul Ray
Regulatory Writer III at Imugene Limited- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Imugene Limited
-
Australia
-
Biotechnology Research
-
1 - 100 Employee
-
Regulatory Writer III
-
Aug 2023 - Present
Sydney, New South Wales, Australia
-
-
-
Precision BioSciences, Inc.
-
United States
-
Biotechnology Research
-
100 - 200 Employee
-
Regulatory Writer III
-
Feb 2019 - Aug 2023
-
-
-
-
Regulatory Writer
-
Jul 2016 - Dec 2018
Raleigh-Durham, North Carolina Area Authors a diverse range of regulatory documents in support of IND and NDA submissions, to include clinical study reports, clinical study protocols, Investigator's Brochures, non-clinical study reports, pharmacology and PK/PD written and tabulated summaries, orphan drug applications, pediatric investigation plans, and regulatory responses (briefing documents). Assumes responsibility for submission of multiple documents with overlapping timelines.
-
-
-
North Carolina State University
-
United States
-
Higher Education
-
700 & Above Employee
-
Post-Doctoral Researcher
-
Sep 2015 - Jul 2016
Raleigh, NC Epigenetic profiling of single cells in nanofluidic devices.
-
-
-
University of North Carolina at Chapel Hill
-
Research
-
1 - 100 Employee
-
Postdoctoral Researcher
-
2013 - Jun 2015
Chapel Hill, NC Toxico-epigenomics in pregnancy-related disorders.
-
-
-
-
Research Associate
-
2006 - 2012
Raleigh, NC Epigenetic alterations and gene transcription in response to toxic metals.
-
-
Education
-
North Carolina State University
Doctor of Philosophy (Ph.D.), Molecular and Cellular Toxicology -
University of Louisiana at Monroe
Bachelor's degree, Toxicology